Effect of Mobile Phone Telemedicine on Diabetes Care
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT01698008
- Lead Sponsor
- University of Nebraska
- Brief Summary
Adult patients with diabetes on insulin are eligible for the study. They will be randomized to a group using standard of care communication and a group using an I phone intervention.
- Detailed Description
Type 1 or type 2 diabetes mellitus subjects who know how to operate and own an iPhone, are between the age of 19 to 75, and are on a basal/bolus insulin regimen will be included in the study. Subjects will be randomized to two groups - iPhone versus standard of care and seen in our clinic at an initial/baseline and three month clinical visit. The control group will e-mail, fax, or call their blood glucose log results once a month for an insulin regimen adjustment through verbal communication with a certified diabetic educator once a month as is already implemented at the Diabetes Center. This group will be compared to the intervention group who will submit their blood glucose log results through an iPhone mobile application, called Diabetes Doctor, once a month for an insulin regimen adjustment by a physician with a text message response. The two groups will have their HbA1c, hypoglycemic events, blood glucose dispersion compliance, quality of life, usability and satisfaction with the use of a mobile application will be assessed at each visit with surveys.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Type 1 or type 2 Diabetes Mellitus on insulin basal/bolus injection
- Own and are able to operate an iPhone
- Type 2 diabetics using only oral medications
- Do not own or know how to operate an iPhone
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Evidence for Improved Diabetic Care With Mobile Phone Application Use Six months Satisfaction and usability was evaluated with a survey for those subjects who used the mobile phone application at the 3 and 6 months period.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The University of Nebraska Medical Center
🇺🇸Omaha, Nebraska, United States
The University of Nebraska Medical Center🇺🇸Omaha, Nebraska, United States